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Abstract
Background: Dendritic arbor simplification and dendritic spine loss in the hippocampus, a limbic structure implicated in 
mood disorders, are assumed to contribute to symptoms of depression. These morphological changes imply modifications in 
dendritic cytoskeleton. Rho GTPases are regulators of actin dynamics through their effector Rho kinase. We have reported that 
chronic stress promotes depressive-like behaviors in rats along with dendritic spine loss in apical dendrites of hippocampal 
pyramidal neurons, changes associated with Rho kinase activation. The present study proposes that the Rho kinase inhibitor 
Fasudil may prevent the stress-induced behavior and dendritic spine loss.
Methods: Adult male Sprague-Dawley rats were injected with saline or Fasudil (i.p., 10 mg/kg) starting 4 days prior to and 
maintained during the restraint stress procedure (2.5 h/d for 14 days). Nonstressed control animals were injected with saline or 
Fasudil for 18 days. At 24 hours after treatment, forced swimming test, Golgi-staining, and immuno-western blot were performed.
Results: Fasudil prevented stress-induced immobility observed in the forced swimming test. On the other hand, Fasudil-
treated control animals showed behavioral patterns similar to those of saline-treated controls. Furthermore, we observed 
that stress induced an increase in the phosphorylation of MYPT1 in the hippocampus, an exclusive target of Rho kinase. 
This change was accompanied by dendritic spine loss of apical dendrites of pyramidal hippocampal neurons. Interestingly, 
increased pMYPT1 levels and spine loss were both prevented by Fasudil administration.
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Conclusion: Our findings suggest that Fasudil may prevent the development of abnormal behavior and spine loss induced by 
chronic stress by blocking Rho kinase activity.
Keywords: behavior, dendritic spines, antidepressant, ROCK inhibitor Fasudil, stress
Introduction
Neuroplasticity, the ability of the brain to change and adapt in 
response to experience and fluctuating environment, involves 
several mechanisms, ranging from synaptic remodeling to func-
tional modification of synapses and neural circuitries. Repeated 
exposure to unpredictable and uncontrollable stressors may 
result in brain modifications that decrease the capacity to 
appropriately respond to subsequent stressors, thus increasing 
the risk for developing mental disorders, including depression 
(McEwen and Gianaros, 2010). Furthermore, several studies have 
shown that functional modifications of the hippocampus, amyg-
dala, prefrontal cortex, and other structures are responsible for 
depression symptoms (Drevets et  al., 2008; Price and Drevets, 
2010). The hippocampus, a stress-sensitive limbic structure, is 
crucial for episodic and spatial memory; these functions are 
impaired in depressive disorder (Austin et al., 2001; Drevets et al., 
2008; Price and Drevets, 2010). Human brain imaging and pre-
clinical studies in rodents have revealed that stress and depres-
sion are associated with reduced hippocampal volume, neuronal 
atrophy, and dendritic spine loss (McEwen and Seeman, 1999; 
Vyas et al., 2002; Fernandez-Guasti et al., 2012; Castaneda et al., 
2015). In addition, the hippocampus participates in the intersec-
tion between cognition and emotion and plays a crucial in the 
pathophysiology of mood disorders (Campbell and Macqueen, 
2004; Femenía et al., 2012). Similar to other studies (Bondi et al., 
2008), we previously reported that chronic stress in rodents pro-
duces anhedonia, impairs associative learning, and increases 
immobility in the forced swimming test (FST) (Bravo et al., 2009; 
Ulloa et al., 2010; Castaneda et al., 2015). Notably, these behav-
ioral modifications are accompanied by dendritic atrophy and 
spine density reduction of pyramidal neurons in the hippocam-
pus and prefrontal cortex (McEwen and Seeman, 1999; Vyas 
et al., 2002; Fernandez-Guasti et al., 2012; Castaneda et al., 2015). 
Overall, this evidence suggests that the mechanisms involved in 
excitatory synapse formation and maintenance can be altered 
in stress-related mood disorders, contributing to the phenotypic 
alterations observed in depressive disorder.
The formation and elimination of dendritic spines are mecha-
nisms by which neuronal connections can be shaped (Chklovskii 
et  al., 2004). The growth of dendrites, filopodia, and dendritic 
spines occurs by protrusive forces of actin polymerization (Luo, 
2002). Thus, it is plausible that the morphological alterations 
observed under chronic stress are produced by changes in sig-
nal transduction pathways that target the reorganization of the 
actin cytoskeleton. Members of the Rho-GTPase family regulate 
actin cytoskeleton dynamics and modulate axonal growth, den-
dritic arborization, and spine growth during development and 
adulthood (Luo, 2000; Nakayama et al., 2000; Tashiro and Yuste, 
2004; Govek et al., 2005; Elia et al., 2006). For instance, activated 
RacGTP-ases stimulate the formation of thin spines (Nakayama 
et al., 2000) and through the activation of p21-activated kinase 1 
trigger the activation of LIM-kinase, which phosphorylates 
and inhibits cofilin, a potent actin-depolymerizing molecule 
(Calabrese et al., 2006). In contrast, RhoA-GTPases promote neu-
ronal dendritic arbor simplification and reduce spine length and 
number (Nakayama et al., 2000; Nakayama and Luo, 2000). RhoA 
signaling is mediated by Rho serine/threonine kinase (ROCK) 
isoforms 1 and 2, the latter being highly expressed in the brain 
and muscle tissue (Hashimoto et  al., 1999). ROCK regulates 
cytoskeleton dynamics by phosphorylation of the myosin light 
chain (MLC) at Ser19, probably facilitating acto-myosin inter-
action (Hirose et  al., 1998), which may produce fast neuronal 
remodeling, such as retraction of dendrites. Furthermore, ROCK 
can phosphorylate and inactivate the myosin phosphatase-
targeting subunit 1 (MYPT1) of MLC phosphatase and may indi-
rectly increase MLC phosphorylation state, favoring acto-myosin 
interaction (Amano et al., 1996).
Studies have shown high immunoreactivity of ROCK2 in 
several brain areas, including pyramidal neurons of the hip-
pocampus (Hashimoto et al., 1999), suggesting a particular role 
of ROCK in these structures of the adult brain. Although ROCK2-
deficient mice display normal brain anatomy, electrophysiolog-
ical studies in hippocampal slices evidenced an impairment 
of both basal synaptic transmission and long-term potentia-
tion (Zhou et  al., 2009). These electrophysiological alterations 
were consistent with modifications in dendritic spine length 
and morphology, accompanied by an increase in activated cofi-
lin (unphosphorylated form). Nonetheless, this study did not 
explore whether the deletion of ROCK2 modifies the behavior 
of animals (Zhou et al., 2009).
Considering that ROCK has several downstream effectors 
and that some of them are related to the regulation of cytoskel-
eton dynamics, studies have evaluated the effect of different 
ROCK inhibitors on brain function. For example, in vascular 
smooth cells, Fasudil increases cerebral blood flow after stroke 
by reducing vasoconstriction (Shin et  al., 2007). Furthermore, 
systemic administration of hydroxyfasudil, an active metabo-
lite of Fasudil, improves the cognitive deficits in aged rats and 
also improves learning and memory in a model of sporadic 
Alzheimer’s disease (Hou et al., 2012). According to the relevance 
of the Rho-ROCK pathway in neuronal morphology in vitro and 
the effect of ROCK inhibitors on cognition, learning, and memory, 
it is particularly important to address whether RhoA signaling 
Significance Statement
This study examined the effects of a ROCK inhibitor, fasudil, on depressive-like behavior and neuronal changes associated with 
exposure to chronic restraint stress in a rodent model of depression. We observed that our stress model induced depressive-like 
behaviors in rats, which was prevented by Fasudil treatment. Furthermore, we observed that chronic stress decreased spine 
density in CA1 pyramidal neurons, modification that was related to an enhancement in phospho-MYPT1 levels, a known ROCK 
effector. These changes were prevented by Fasudil treatment, a ROCK inhibitor.
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is being altered under some pathological conditions, such as 
depressive disorders. Recently, in an animal model of depression 
induced by chronic restraint stress, we observed an increase in 
hippocampal phospho-MYPT1 levels, suggesting that ROCK2 is 
activated by this experimental paradigm (Castaneda et al., 2015). 
Interestingly, the rise in phospho-MYPT1 levels was associated 
with the spine loss observed in secondary dendrites of CA1 
pyramidal neurons of the hippocampus (Castaneda et al., 2015). 
Moreover, it has been demonstrated that bilateral infralimbic 
administration of Y-27632, a specific ROCK inhibitor, promotes 
antidepressant-like effects in naive rats that are similar to those 
produced by the antidepressant fluoxetine (Inan et al., 2015).
Considering that stress increases immobility in the FST, 
an effect that is accompanied by a dendrite spine loss in CA1 
pyramidal neurons and along with an increase in hippocam-
pal phospho-MYPT1 levels, indicative of RhoA-ROCK pathway 
activation (Castaneda et al., 2015), we hypothesized that phar-
macological inhibition of ROCK with Fasudil prevents both the 
increase in immobility in FST and dendrite spine loss in the hip-
pocampus of rats under chronic restraint stress paradigm, an 
animal model of depression.
Materials and Methods
Animals
The Sprague-Dawley rats used in these experiments were 
obtained from the Faculty of Chemical and Pharmaceutical 
Sciences, Universidad de Chile. Efforts were made to mini-
mize the number of animals and their suffering. The rats 
were handled according to guidelines outlined and approved 
by the Ethical Committee of the Faculty of Chemical and 
Pharmaceutical Sciences, Universidad de Chile and the Science 
and Technology National Commission (CONICYT), in compli-
ance with the National Institutes of Health Guide for Care and 
Use of Laboratory Animals (NIH Publication, 8th Edition, 2011).
The adult male Sprague-Dawley rats (250–280 g) were housed 
in groups of 4/cage in a temperature (22–23ºC) and humid-
ity (55–65%) controlled room with a standard light: dark cycle 
(12 hours:12 hours). Food (standard rat chow) and water were 
freely provided, except when restraint stress was applied. The 
rats were handled once per day for 7 days prior to initiating the 
experimental procedures. The handling procedure consisted of 
picking up the rat by its body, weighing it, and finally returning 
it to its home cage.
Restraint Stress and Pharmacological Treatment
An animal model of chronic restraint stress was used to evalu-
ate changes in ROCK activity and the effect of the ROCK inhib-
itor Fasudil on behavior. A  dose of 10  mg/kg i.p. was selected 
based on the observation that i.p. administration of 5 to 15 mg/
kg of Fasudil was previously reported to induce neuroprotection 
in the CNS (Wu et al., 2012; Song et al., 2013; Wei et al., 2014). The 
rats were randomly assigned to weight-matched groups that 
received one of the following treatments prior to the restraint 
protocol: (1) unstressed control animals injected every day for 
18 days with saline (0.9% NaCl) (CONTROL, n = 16) or with 10 mg/
kg Fasudil (LC Laboratories, Woburn, MA) (FASUDIL, n = 13), and 
(2) stressed animals injected for 18  days with saline (STRESS, 
n = 16) or 10 mg/kg Fasudil (STRESS-FASUDIL, n = 15). All injec-
tions were carried out i.p. 15 minutes prior to the stress protocol. 
To examine the preventive action of Fasudil on chronic stress 
effects, the stress procedure was initiated 4 days after the first 
drug or saline was administered. In this study, we used restraint 
stress as previously described, which consisted of placing the 
rats in Plexiglas tubes (25 x 8 cm) that were wide enough to allow 
comfortable breathing but restricting the movement of the ani-
mals for 2.5 h/d for 14 consecutive days. Every stress session was 
performed between 9:00 am and 12:00 pm to avoid any effects 
due to changes in circadian rhythms. After the procedure, the 
animals were returned to their respective cages. After vehicle or 
Fasudil administration, unstressed animals were maintained in 
their home cages and left in another room. Twenty-four hours 
after the last treatment, animals were evaluated in a behavioral 
test (described below) or were killed to obtain either brain tissue 
to conduct morphological analyses, or the hippocampus for pro-
tein level determinations by immuno-western blot.
FST
The behavioral test consisted of blinded observations, which 
was carried out 24 hours after the last restraint procedure, in 
a quiet room. This test was performed as previously described 
(Lucki, 1997). A  transparent Plexiglas cylinder (50  cm high x 
20 cm wide) was filled up to a depth of 30 cm with water at 24ºC. 
Four hours after the last stress session and Fasudil treatment 
on day 14, rats were trained for 15 minutes by placing them in 
the water-filled cylinder. On day 15 (24 hours after cessation 
of stress and Fasudil treatment), the rats were subjected to 5 
minutes of forced swimming and escape behaviors (climbing 
and swimming) that were registered by trained observers who 
were blind to the treatments. Climbing was defined as upward-
directed movements of the forepaws along the side of the swim 
chamber, while swimming consisted of movements throughout 
the swim chamber. Duration of immobility was defined as the 
time the animal was not actively involved in escape responses 
(i.e., total time of the test minus the time the animal spent 
climbing or swimming).
Golgi Staining and Evaluation of Dendritic Spine 
Density
After decapitation, one brain hemisphere was used for mor-
phological studies and in the other, the hippocampus was dis-
sected and rapidly frozen in liquid nitrogen and stored at -80°C. 
The FD Rapid GolgiStain kit (FD Neuro Technologies, Baltimore, 
MD) was used as recently described (Castaneda et al., 2015). 
Secondary apical dendrites of pyramidal neurons from the 
CA1 region were selected for spine analyses (bregma -2.3 to 
-4.3) (Paxinos and Watson, 1982). The criteria for the selection 
of Golgi-impregnated neurons for morphological analyses were 
recently described (Castaneda et al., 2015). Confocal z-stacks of 
identified intersections were captured on a Zeiss LSM 700 con-
focal laser scanning microscope. Each designated segment was 
located in the microscope field, and confocal stacks of 15 to 30 
digital images, separated by a z-step of 0.5 to 1 μm, were cap-
tured using a Plan-Apochromat 40 × 1.4 NA Zeiss oil-immersion 
objective. Protrusions in direct connection with the dendritic 
shaft, irrespective of their morphological characteristics, were 
considered as spines. A mushroom spine type was identified 
when its head diameter exceeded 0.6 μm; the remaining spines 
(filopodia, stubby and other protrusions) were classified as “non-
mushroom.” Spines were counted in segments of 8 µm, starting 
from the origin of the branch, along a distance of 80 µm of the 
secondary dendrite. The number of spines at a given distance 
from the origin of the branch were then averaged using all of 
the neurons from the same animal (at least 6 cells/animal), and 
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these data were pooled with the mean of the other animals 
belonging to the same experimental group. The total number of 
spines corresponded to the sum of spines along the dendritic 
length of 80 µm.
Immunoblot Analysis
Whole hippocampus was homogenized in a glass-glass homog-
enizer in the presence of 50  mM Tris (pH 7.4), 150  mM NaCl, 
0.5  mM EGTA, 0.5  mM EDTA, 0.5  mM DTT, 0.125  mM Na3VO4, 
0.2 mM PMSF, 2 µg/mL leupeptin, 2 μg/mL aprotinin, 2 mM NaF, 
0.25 mM Na2P2O7, and 1% Triton X-100 and then sonicated on ice 
for 5 minutes. After centrifuging lysates at 17 860 x g for 30 min-
utes, the supernatant was collected and a sample was saved for 
protein determination using the bicinchoninic method (Pierce 
BCA Protein Assay Kit ThermoFisher Scientific). The remaining 
supernatant was boiled immediately in sample loading buffer. 
A total of 25 to 50 μg of each protein extract was resolved on 12% 
SDS-polyacrylamide gels and then blotted onto 0.2 μm nitrocel-
lulose (for detection of total and phosphorylated form of LIMK 
and MYPT1) or 0.2 μm PVDF membranes (for determination of 
total and phosphorylated form of cofilin). After blocking, mem-
branes were incubated overnight with the appropriate primary 
antibodies diluted in blocking solution and then, with their 
corresponding secondary antibody (Table  1), as we described 
previously (Castaneda et  al., 2015). All membranes were then 
incubated with enhanced chemiluminescent substrate (Perkin 
Elmer Life Sciences, Boston, MA) and detected by a chemilumi-
nescence imager (Syngene). Band intensities were determined 
and analyzed using the UN SCAN IT software. The levels of 
β-actin were used to verify equivalent protein loading. For detec-
tion of total MYPT1 and LIMK, blots were stripped in Ponceau S 
solution for 1 hour, then incubated with the appropriate dilution 
of the antibodies (Table  1). For detection of total cofilin, blots 
were stripped with ReBlotPlus Mild Antibody Stripping Solution 
during 10 minutes and were then incubated overnight with an 
appropriate dilution of anti-cofilin (Table  1). After rinses, the 
procedure continued as described above.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism 
(GraphPad Software Inc., San Diego, CA). Data are expressed as 
mean ± SEM and were analyzed by 2-way ANOVA followed by 
Tukey’s post-hoc test.
Results
Effect of Stress and Fasudil Treatment on Body 
Weight Gain
Because basic studies have shown that stress affects physi-
ological parameters related to hypothalamic-pituitary-adrenal 
activation, including energy mobilization mediated by gluco-
corticoid action, we tested whether mild restraint and Fasudil 
led to changes in body weight gain. We determined the per-
centage of body weight gain for each day either prior (days -4 
to 0) or during the stress procedure (day 1 to day 14) compared 
with the initial weight at the beginning of the stress procedure 
(day 1), expressed as daily weight x 100/start weight at day 1. 
We observed no difference in weight gain prior to the beginning 
of the stress procedure, in which rats were injected with saline 
(CONTROL) or Fasudil (FASUDIL) (Figure 1A). Nonetheless, 2-way 
ANOVA analysis performed with the daily variation of weight 
gain during the 14 days of stress and Fasudil administration 
showed that treatment (or experimental groups) (F3,56 = 7.45, 
P < .0003), time (days) (F13,56 = 132.2, P < 0.0001), and the inter-
action between these factors (F39,56 = 5.54 P < .0001) had a sig-
nificant effect on body weight gain. Moreover, Tukey’s post-hoc 
analysis indicated that stressed rats injected either with saline 
solution (STRESS) or Fasudil (STRESS-FASUDIL) showed a reduc-
tion in weight gain observable after 7 days of stress (Figure 1A). 
Additionally, 2-way ANOVA analysis of both factors at the end 
point of treatment showed that stress (F1,56 = 15.93, P = 0.0002), 
but not Fasudil treatment (F1,56 = 0.8979, P = 0.3474), had a sig-
nificant effect on body weight gain (Figure 1B). The interaction 
between both factors was not significant (F1,56 = 0.03771, P = 
.8467). Moreover, no significant change in adrenal weight was 
observed by restraint stress (CONTROL, 28.9 ± 1.3 mg vs STRESS, 
26.23 ± 2.2 mg) and Fasudil, compared with control (24.1 ± 1.4 
mg) and stressed rats (24.0 ± 1.3 mg). Thus, the restraint stress, 
but not Fasudil, produced a reduction in weight gain, but this 
was not related to changes in adrenal weight, suggesting that 
our stress model is mild in terms of HPA activation.
Effects of Fasudil on Activity in the FST
The antidepressant effect of Fasudil was examined in the FST, 
which is a highly reliable behavioral assay for the detection 
of antidepressant activity exerted by pharmacological agents 
(Cryan et al., 2002). As shown in Figure 2, control animals spent 
Table 1. Western-Blot Conditions and Antibodies
Antibody Host, Isotype Source /Catalog No. Blocking Solution Primary Antibody Secondary Antibody
β-Actin Mouse Sigma-Aldrich/A5316 3% nonfat milk
-TBS 0.1% Tween-20
1:10 000; 1 h 1:10 000; 2 h
pThr508-LIMK Rabbit Sigma-Aldrich/SAB 4504460 3% nonfat milk
-TBS 0.1% Tween-20
1:500; overnight 1:10 000; 2 h
LIMK 1 Rabbit Sigma-Aldrich/L2290 1% nonfat milk
-TBS 0.1% Tween-20
1:4000; overnight 1:10 000; 2 h
pSer3-cofilin Rabbit Cell Signaling/77G2 5% BSA
-TBS 0.1% Tween-20
1:1000; overnight 1:10 000; 2 h
cofilin Rabbit Cytoskeleton/ACFL02 3% nonfat milk
-TBS 0.1% Tween-20
1:8000; overnight 1:10 000; 2 h
pThr853-MYPT1 Rabbit Cell Signaling/4563 5% nonfat milk
-TBS 0.1% Tween-20
1:500; overnight 1:10 000; 2 h
MYPT1 Rabbit Cell Signaling/2634 5% nonfat milk
-TBS 0.1% Tween-20
1:250; overnight 1:10 000; 2 h
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approximately 60% of the time in active response, that is, swim-
ming and climbing. The 2-way ANOVA analysis showed a signifi-
cant main effect of Fasudil treatment (F1,21 = 36.59, P < .0001) but 
not for stress (F1,21 = 0.004, P = .95) on spent time in immobility. 
Nonetheless, the interaction between these factors was signifi-
cant (F1,21 = 91.75, P < .0001). Tukey post-hoc analysis showed that 
stressed animals increased their time in immobility (P < .0001), 
which was prevented by Fasudil (P < .0001), suggesting an anti-
depressant-like effect of Fasudil. In addition, the 2-way ANOVA 
analysis on spent time in climbing showed a significant main 
effect of Fasudil treatment (F1,21 = 40.11, P < .0001) but not of 
stress (F1,21 = 1.559, P = .226). We found a significant interaction 
between stress and Fasudil treatment (F1,21 = 39.19, P < .0001), 
evidencing that Fasudil treatment in stressed animals induces 
an increment in the spent time in climbing, indicating that this 
response is higher than control rats (P < .001). In the case of the 
swimming behavior, we observed that neither stress (F1,21 = 1.45, 
P = .1578) nor Fasudil treatment (F1,21 = 1.850, P = .1882) showed a 
significant effect.
Effects of Stress and Fasudil on Dendritic Spine 
Number of CA1 Pyramidal Cells
We analyzed the effect of stress and Fasudil on dendritic spine 
number of secondary apical dendrites from pyramidal neurons 
of CA1. We evaluated whether treatments modified the number 
of spines regardless of their morphological features. Figure 3A 
shows an example of a CA1 pyramidal neuron, and the mag-
nification shows the segment of a secondary dendrite used to 
count the number of spines along 80 µm. Figure 3B shows the 
magnification of a segment of a secondary dendrite, where the 
effect of treatments on the density of protrusions along the den-
drite can be observed. When the total number of spines counted 
in 80 µm was analyzed by the 2-way ANOVA test, we observed 
a significant main effect of stress (F1,15 = 5.666, P < .03) but not of 
Fasudil treatment (F1,15 = 1.67, P < .3); nonetheless a significant 
interaction was detected (F1,15 = 10.99, P < .005). Post-hoc analy-
sis revealed that stress induced a reduction in spine density 
(P < .01) and that Fasudil prevented the stress-induced reduction 
in spine density (Figure 3C). We segregated the spines accord-
ing to their morphology to visualize a differential effect of treat-
ments. We observed that neither stress (F1,15 = 0.06797, P = .7979) 
nor Fasudil treatment (F1,15 = 0.9393, P = .3478) induced variation 
in the number of mushroom spines (Figure 3D). Nonetheless, we 
found a significant effect of stress (F1,15 = 9.750, P < .007), Fasudil 
treatment (F1,15 = 4.863, P = .0435), and interaction between these 
factors (F1,15 = 6.324, P = .0238) on the number of nonmushroom 
spines in 80 µm (Figure 3E). Furthermore, Fasudil administration 
prevented the stress-induced reduction in spines (Figure 3C), 
mainly in nonmushroom spines (Figure 3E).
Effect of Stress and Fasudil on Phosphorylation 
Levels of MYPT1, LIMK, and Cofilin in Hippocampus 
Extract
To evaluate whether chronic stress and Fasudil modulate ROCK 
activity, we evaluated the phosphorylation state of myosin 
phosphatase targeting protein 1 (MYPT1, also known as Myosin 
Binding Subunit) in its Thr853 residue, an exclusive target of 
ROCK. We observed a significant main effect of stress (F1,19 = 21.19, 
Figure 1. Effect of chronic restraint on body weight gain. (A) The graph represents mean ± SEM of the change in body weight as a percentage of the initial weight for 
control animals that were left untreated (CONTROL, n = 16) or treated with Fasudil (FASUDIL, n = 13), untreated animals subjected to chronic restraint stress (STRESS, 
n = 16) and Fasudil-treated animals subjected to chronic restraint (STRESS-FASUDIL, n = 15). Two-way ANOVA followed by Tukey’s post-hoc analysis. CONTROL vs STRESS 
*P < .05, **P < .01, ***P < .001, ****P < .0001. FASUDIL vs STRESS-FASUDIL ++P < .01, +++P < .001, ++++P < .0001. (B) Variation of body weight gain was evaluated at the endpoint 
of treatments. Two-way ANOVA, ***P < .001.
Figure 2. Effects of Fasudil administration on immobility and active response 
duration in the forced swimming test (FST). Bar graph indicates mean ± SEM 
of total time spent in immobility and climbing behaviors. Two-way ANOVA fol-
lowed by Tukey’s post-hoc analysis indicated that Fasudil-treated animals (FAS-
UDIL, n = 5) showed similar durations of immobility and active behaviors as 
animals injected with saline (CONTROL, n = 7). Stressed animals (STRESS, n = 
7) spent more time in an immobile posture and significantly reduced climbing 
behavior. Chronic treatment with Fasudil (STRESS-FASUDIL, n = 6) prevented the 
stress-induced immobility by increasing active behaviors, mainly in the form of 
climbing. **P < .01; ***P < .001; ****P < .0001.
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P = .0002), Fasudil treatment (F1,19 = 13.74, P = .0015), and strong 
interaction between factors (F1,19 = 10.49, P = .0043) on the levels 
of p-MYPT1, relative to MYPT1 (Figure 4B). Post-hoc analysis 
showed that stress induced an increase of 50% in p-MYPT1 lev-
els (P < .0001), variation that was prevented by Fasudil (P < .001) in 
the hippocampus of stressed animals, an effect probably related 
to ROCK inhibition.
We also evaluated changes in the phosphorylation state of 
LIMK, which is a common effector of Rho and RAC GTPases in 
vitro. We observed that neither stress (F1,14 = 0.955, P = .345) nor 
Fasudil treatment (F1,14 = 1.028, P = .328) influenced p-LIMK lev-
els, relative to total LIMK (Figure  4C). Accordingly, there were 
no significant effect of stress (F1,18 = 3.09, P =  .095) and Fasudil 
(F1,18 = 0.87, P  =  .361) on p-cofilin levels relative to total cofilin 
(Figure 4D).
Discussion
Alteration in neuronal morphology related to dendritic arbor 
and spines are hallmarks of several psychiatric disorders, 
including major depressive disorders (Licznerski and Duman, 
2013). Stress exposure may contribute to the development of 
depression (Kendler et al., 1999), and several studies support 
the idea that stress-induced brain atrophy might be respon-
sible, in part, for the phenotypic characteristics of depressive 
disorders (Pittenger and Duman, 2008). The observed morpho-
logical changes include dendritic tree simplification accompa-
nied by a reduction in the number of dendritic spines (Lin and 
Koleske, 2010). We have recently described that dendritic spine 
loss in the hippocampus of chronically stressed rats is related 
to an increase in phospho-MYPT1, a well-known downstream 
Figure 3. Effects of stress and Fasudil treatment on spine number along apical dendrites of pyramidal neurons in the CA1 hippocampal region. (A) The photograph 
shows a representative isolated Golgi-stained pyramidal neuron of the CA1 hippocampal region of control animals, and a magnification of a secondary dendritic branch 
in the stratum radiatum area, which was used to count spines. (B) Photographs show the qualitative effects of stress and Fasudil treatment on spine density from a 
secondary dendrite. (C) Effect of treatments on total spine number in a dendritic segment of 80 µm. Two-way ANOVA followed by Tukey’s post-hoc analysis revealed 
that stress induced a reduction in spine density and that Fasudil prevented the stress-induced reduction in spine density. (D) Effect of treatments on mushroom spine 
number in a dendritic segment of 80 µm. (E) Effect of treatments on nonmushroom spine number in a dendritic segment of 80 µm. Two-way ANOVA followed by Tukey’s 
post-hoc analysis indicated that stress induced a reduction in spine density and that Fasudil prevented the stress-induced reduction in spine density. Values are the 
mean ± SEM (CONTROL, n = 5; FASUDIL, n = 4; STRESS, n = 5; STRESS-FASUDIL, n = 5). *P < .05; **P < .01.
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target of ROCK, suggesting that stress promotes the activation 
of the RhoA-ROCK pathway and therefore induces changes 
in cytoskeleton dynamics (Castaneda et  al., 2015). Our main 
findings in the present study performed in rats can be sum-
marized as follows: Fasudil, a ROCK inhibitor, prevents the 
stress-induced immobility observed in the FST, spine loss in 
CA1 neurons of the hippocampus, and increase in pMYPT1 
levels.
By using a chronic restraint stress paradigm in rats, we have 
previously reported anhedonic behavior accompanied by a sig-
nificant reduction in escape-directed behavior (Bravo et  al., 
2009; Castaneda et al., 2015). In the present study, we tested the 
effect of Fasudil in the FST, a test widely used to assess anti-
depressant activity of pharmacological agents (Porsolt et  al., 
1979; Cryan et al., 2005). It has been described that all antide-
pressant drugs reduce behavioral immobility. However, those 
antidepressants that increase serotonergic neurotransmission 
predominantly increase swimming behavior, whereas those 
that increase catecholaminergic neurotransmission increase 
climbing behavior (Cryan et  al., 2005). We demonstrated that 
Fasudil treatment reduced stress-induced immobility through 
an increase in active responses, mainly in climbing behavior, 
to a level that was even higher than in control rats. Notably, 
the effect of Fasudil in stressed animals resembles the action 
of the antidepressant DMI (Bravo et  al., 2009), which blocks 
the norepinephrine transporter. However, in our model, we do 
not know whether chronically administered Fasudil modifies 
noradrenergic neurotransmission. Furthermore, a recent study 
demonstrated that acute bilateral microinjection of the ROCK 
inhibitor Y-27632 (0.25 μg) into the infralimbic cortex of naïve 
rats increased active behavior during the FST (swimming and 
climbing) (Inan et al., 2015), similarly to drugs with dual effects 
on norepinephrine and serotonin transporters that extend 
the duration of both active behaviors (Detke et al., 1995, 1997). 
Thus, it seems plausible that drugs that do not share the same 
pharmacological profile, that is, antidepressant molecules and 
Figure 4. Effect of stress and Fasudil on the phosphorylation state of proteins related to actin dynamics, myosin phosphatase targeting subunit 1 (MYPT1), LIMK, and 
cofilin. (A) Pathways related to RAC and RhoA activation and their downstream effectors. (B) phospho-MYPT1 expressed as a ratio of phospho-MYPT1 relative to MYPT1. 
Two-way ANOVA followed by Tukey’s post-hoc analysis indicated an increase in p-MYPT1 levels that was prevented by Fasudil. (CONTROL n = 7; FASUDIL n = 5; STRESS 
n = 6 and STRESS-FASUDIL n = 5). ***P < .001, ****P < .0001 (C) phospho-LIMK expressed as a ratio of phospho-LIMK relative to LIMK. (CONTROL n = 5; FASUDIL n = 4; 
STRESS n = 5 and STRESS-FASUDIL n = 4). (D) phospho-cofilin expressed as a ratio of phospho-cofilin relative to cofilin (CONTROL n = 6; FASUDIL n = 5; STRESS n = 6 and 
STRESS-FASUDIL n = 5). β-Actin was used as the loading control. Values are the mean ± SEM.
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ROCK inhibitors, may converge into a common intracellular 
pathway that underlies the action of antidepressants. The spec-
ificity of the FST for screening antidepressant-like agents has 
been widely questioned (Petit-Demouliere et al., 2005), because 
a large variety of nonantidepressant drugs have been shown to 
increase the locomotion that can be erroneously interpreted 
with an antidepressant-like effect (for review, see Yin et  al., 
2016). For this reason, some studies that evaluate the effects of 
antidepressant drugs in FST also evaluate potential hyperactiv-
ity in the open field arena. Although we did not use parallel test 
to exclude drug-induced locomotor false positives, there is a 
report indicating that Fasudil did not change locomotor activity 
in the open field test (Yoshimi et al., 2010). Additionally, we have 
observed that the total arm visits in elevated plus-maze was 
similar in control and stressed animals with or without Fasudil 
administration, suggesting that treatments did not alter loco-
motor activity (data not shown).
On the other hand, studies have used FST to visualize the 
“depressogenic effect” of various types of stress; however, 
their effects seem to be dependent on the stress paradigm 
used (for review, see Bogdanova et al., 2013). Some authors 
have proposed that the immobility observed during the test 
session of the FST indicates that the animal “learned” a strat-
egy to save energy during the FST training session. Thus, in 
this scenario, the increase in the time spent in immobility 
does not seem to be related to “behavioral despair” or depres-
sive-like symptoms (for review, see de Kloet and Molendijk, 
2016). Considering that in our stress model Fasudil increases 
the time spent in climbing in the FST, the increment in this 
active response may be indicative of changes in the activity of 
some neural circuits related to this behavior promoted by the 
ROCK inhibitor. In the context of depressive behavior, motiva-
tion has been evaluated by the exposure of rodents to an ines-
capable stressor, such as the tail-suspension test or FST, and 
quantifying the proportion of time spent performing escape-
related behavior (struggling) relative to time spent immobile. 
Recently, and by using an optogenetic approach, acute and 
selective inhibition of ventral tegmental area (VTA) dopamin-
ergic neurons was shown to promote several depression-like 
behaviors, such as anhedonia (sucrose consumption) and 
reduced struggling behavior in the tail-suspension test (Tye et 
al., 2013). Interestingly, this study also showed that the phasic 
activation of VTA dopaminergic neurons reverts the reduction 
in escape behavior (struggling) induced by chronic mild stress 
(Tye et al., 2013). Furthermore, other optogenetic approaches 
revealed that a selective population of neurons in medial 
prefrontal  cortex (PFC) is implicated in the active response 
to behavioral challenges (Warden et al., 2012). More recently, 
optogenetic approaches have also shown that activation of 
the ventral-hippocampus-medial PFC pathway is required 
for the sustained action of ketamine antidepressant action, 
observed as an increase in climbing in the FST (Carreno et al., 
2016). Although a similar mechanism probably operates in our 
stress model, the suggested Fasudil antidepressant action in 
the FST must be interpreted with caution, and further stud-
ies are required to prove its action on specific circuits that 
are sensitive to stress, such as those related to motivated 
behavior.
Structural neuronal changes within the hippocampus and 
the prefrontal cortex are increasingly recognized as key to the 
pathophysiology of depression (Pittenger and Duman, 2008). 
A reduction in spine densities in CA1 neurons has been associ-
ated with depression-like behaviors in several animal models of 
depression induced by restraint stress or by chronic exposure 
to light at night, suggesting an altered glutamatergic excitatory 
neurotransmission in the hippocampus (Bedrosian et al., 2012; 
Fernandez-Guasti et  al., 2012; Castaneda et  al., 2015; Huang 
et  al., 2015). Some studies have reported that antidepressant 
drugs with different primary mechanisms of action such as imi-
pramine and fluoxetine (Bessa et  al., 2009) revert both behav-
ioral deficits and spine loss in CA3 (Bessa et  al., 2009) caused 
by stress. Accordingly, we next analyzed the potential contribu-
tion of Fasudil on dendritic spine density that may explain its 
stress preventive effect on depression-like behaviors. Thus, in 
the present study, we found that stress-induced spine loss (non-
mushroom spines) in secondary dendrites of CA1 pyramidal 
neurons was prevented by Fasudil treatment, suggesting that 
ROCK inhibition and perhaps other kinases can modify spine 
density. Recently, it was shown that primary hippocampal neu-
rons acutely exposed to Y-27632, a ROCK inhibitor, specifically 
increased the number of filopodia and thin spines (Swanger 
et  al., 2015). Hence, this evidence suggests that ROCK inhibi-
tion promotes variation in the density of spines, mainly the 
immature forms.
The effect of Fasudil may be related to modulation of the 
cytoskeleton in vivo that favors spine stability, an effect that 
correlates well with the observed antidepressant-like action of 
this drug in stressed animals. In accordance with this, ROCK 
directly phosphorylates MLC, at least in vitro (Amano et  al., 
1996), and probably favors actomyosin interaction and contrac-
tion. In addition, some studies have indicated that ROCK acti-
vates the LIMK-cofilin pathway (Maekawa et al., 1999), but we 
found that phosphorylation levels of this kinase are insensitive 
to stress and Fasudil treatment. Moreover, ROCK2 activity may 
indirectly increase the level of phospho-MLC by phosphorylat-
ing the Thr853 residue of the MLC phosphatase regulator MYPT1 
(Hartshorne et  al., 1998; Somlyo and Somlyo, 2000; Somlyo 
et al., 2000), resulting in a decrease in MLC phosphatase activity 
(Kimura et al., 1996). Recently, we reported a rise in phospho-
MYPT1 levels in the hippocampus of stressed animals and con-
sidering that this protein is an exclusive target of ROCK (Grassie 
et  al., 2011), we suggested that chronic stress activates ROCK 
(Castaneda et  al., 2015). The present study showed that both 
factors, increased phospho-MYPT1 levels and reduced spine 
density triggered by chronic stress, are prevented by Fasudil, 
suggesting that this drug may mediate those effects by inhibit-
ing ROCK activity.
Overall, this evidence suggests that the disruption of the 
Rho-ROCK pathway and/or inhibition of other kinases by Fasudil 
seem to exert antidepressant-like actions, probably by prevent-
ing spine loss in some areas (e.g., hippocampus). However, fur-
ther studies are necessary to confirm whether Fasudil acts on 
similar substrates in different brain areas. We should also con-
sider that Fasudil, through the inhibition of ROCK, may affect 
several transduction pathways. In vivo reports have shown that 
i.p. administration of Fasudil in a dose similar to the present 
study (10 mg/kg) implicated ROCK in the negative regulation of 
PTEN activity and the enhancement of AKT activity, a neuropro-
tective transduction pathway (Wu et al., 2012). Moreover, many 
new effects of Fasudil have been described, particularly in the 
CNS. It has been shown that systemic administration of Fasudil 
protects against ischemia (15  mg/kg) (Wei et  al., 2014) and 
attenuates neuronal apoptosis and proinflammatory cytokine 
production (5–10  mg/kg) (Song et  al., 2013) in animals models 
of neurodegeneration. Interestingly, diverse evidences have 
situated neuroinflammation and proinflammatory cytokines as 
principal players in depressive disorder pathogenesis and recur-
rence (Slavich and Irwin, 2014). Thus, it remains to be elucidated 
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whether Fasudil, through its antidepressant-like actions and 
preventive effect on dendritic spine loss, are related to ROCK 
inhibition or to other kinases sensitive to this drug and/or are 
associated with modulatory effects on glial and inflammatory 
cells in the CNS. However, considering that systemic admin-
istration of Fasudil may act as a potent vasodilator, it will be 
important to consider this action in vivo, which may mediate 
not only effects on peripheral organs but also cause protective 
effects in the brain.
Conclusion
The present study suggests that Fasudil could prevent both 
increase in immobility in the FST and spine loss induced by 
chronic restraint stress in the rat hippocampus. Although fur-
ther experiments are necessary to reveal the molecular mecha-
nisms underlying the Fasudil-induced improvement in activity 
level in the FST and spine loss prevention, the present results 
can be considered as an initial step by providing support for the 
hypothesis that ROCK inhibition initiates a cascade of events 
that can prevent stress-induced behavior and spine loss. Finally, 
our findings offer new perspectives on pharmacological inter-
vention in depressive disorders.
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